Search

The worldwide health burden of colorectal cancer is still substantial, and traditional chemotherapeutic drugs sometimes have poor selectivity, which can result in systemic toxicity and unfavorable side effects. For colon‐specific medication delivery, bioengineered carbohydrate polymers have shown promise as carriers. They may enhance treatment effectiveness while minimizing systemic exposure and associated side effects. The unique properties of these manufactured or naturally occurring biopolymers, such as hyaluronic acid, chitosan, alginate, and pectin, enable targeted medicine release. These qualities can be changed to meet the physiological needs of the colon. In the context of colorectal cancer therapy, this article provides a comprehensive overview of current developments and prospective future directions in the field of bioengineered carbohydrate polymer synthesis for colon‐specific drug delivery. We discuss numerous techniques for achieving colon‐targeted drug release, including enzyme‐sensitive polymers, pH‐responsive devices, and microbiota‐activated processes. To increase tumor selectivity and cellular uptake, we also examine the inclusion of active targeting approaches, such as conjugating specific ligands. Furthermore, we discuss the potential of combination treatment strategies, which use the coadministration of numerous therapeutic medications to target multiple pathways implicated in cancer growth and address drug resistance mechanisms. We address recent biomimetic advances that potentially improve the biocompatibility, cellular uptake, and tumor penetration of carbohydrate polymer‐based nanocarriers. These methods involve protein corona engineering and cell membrane coating. Furthermore, we look at the possibility of intelligent and sensitive systems that may adjust their behaviors in response to certain inputs or feedback loops, allowing for precise and regulated drug distribution. [ABSTRACT FROM AUTHOR]

AbstractQuantum dots (QDs) have emerged as transformative nanomaterials in drug delivery due to their unique optical and electronic properties, such as tunable fluorescence, high surface area and size-dependent emission in pharmaceutical origin. When integrated with polymers, this hybrid system offers enhanced functionality for targeted, controlled and stimuli-responsive drug delivery. This review focuses on the synthesis and application of quantum dot-polymer composites in drug delivery, emphasizing their ability to improve drug targeting, sustained release and real-time imaging in therapeutic applications. The multifunctionality of these systems enables personalized medicine approaches, particularly in cancer therapy and neurological disorders. Despite their promising potential, concerns related to toxicity and scalability pose significant challenges for their widespread clinical use. Ongoing research efforts are focused on developing more biocompatible QDs, optimizing the design of polymer-QD hybrids and addressing regulatory hurdles. This review, we believe, provides a comprehensive analysis of current advancements in quantum dot-based drug delivery systems and outlines future directions to overcome the existing limitations and enhance clinical applicability. The integration of quantum dots with polymers represents a significant leap forward in the field of nanomedicine, offering the potential for highly efficient, precise and safe drug delivery platforms. [ABSTRACT FROM AUTHOR]